Annovis BioAdvance News Portfolio News

Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update

By WebmasterMay 4, 2022November 1st, 2024No Comments

Annovis Bio Announces First Quarter 2022 Results and Provides Corporate Update

Previous PostRelmada Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
Next PostRelmada Therapeutics Announces Publication of REL-1017 Preclinical Data in Frontiers in Pharmacology